ZAHRA HARRISON: Open Payments
NPI 1659529485 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,846 in 81 payments from 19 companies in 2025. Trend: 2023 $2,221 · 2024 $2,588 · 2025 $3,846
Food & beverage: $2,394Travel & lodging: $1,441Education: $10
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 6 | $2,049 |
| GENZYME CORPORATION | 10 | $422 |
| Janssen Biotech, Inc. | 15 | $343 |
| ABBVIE INC. | 12 | $226 |
| Gilead Sciences, Inc. | 6 | $219 |
| QOL Medical, LLC | 6 | $106 |
| Celltrion USA Inc. | 6 | $104 |
| Madrigal Pharmaceuticals | 4 | $85 |
| Lilly USA, LLC | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
Products named: DUPIXENT, TREMFYA, RINVOQ, Sucraid, VEGZELMA, Epclusa, REZDIFFRA, OMVOH.
Industry payments across CO — which companies pay providers there.
